Select Medical Holdings Co. (NYSE:SEM) Stock Position Raised by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC lifted its stake in shares of Select Medical Holdings Co. (NYSE:SEM) by 7.3% during the fourth quarter, Holdings Channel reports. The firm owned 85,099 shares of the health services provider’s stock after purchasing an additional 5,756 shares during the quarter. Segall Bryant & Hamill LLC’s holdings in Select Medical were worth $1,604,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of SEM. JPMorgan Chase & Co. raised its holdings in Select Medical by 9.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 416,299 shares of the health services provider’s stock worth $14,516,000 after buying an additional 36,905 shares during the period. Argent Capital Management LLC raised its holdings in shares of Select Medical by 79.8% during the fourth quarter. Argent Capital Management LLC now owns 55,144 shares of the health services provider’s stock valued at $1,039,000 after acquiring an additional 24,471 shares during the period. Geode Capital Management LLC lifted its position in shares of Select Medical by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock valued at $85,180,000 after acquiring an additional 46,880 shares in the last quarter. Sanctuary Advisors LLC boosted its stake in Select Medical by 122.8% in the 4th quarter. Sanctuary Advisors LLC now owns 52,175 shares of the health services provider’s stock worth $1,035,000 after purchasing an additional 28,759 shares during the period. Finally, Point72 Asset Management L.P. grew its position in Select Medical by 144.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock worth $71,825,000 after purchasing an additional 1,216,263 shares in the last quarter. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Stock Performance

Shares of NYSE SEM opened at $16.81 on Friday. Select Medical Holdings Co. has a one year low of $16.20 and a one year high of $40.98. The business’s 50-day moving average price is $18.38 and its two-hundred day moving average price is $25.08. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The company has a market capitalization of $2.17 billion, a P/E ratio of 10.19, a price-to-earnings-growth ratio of 0.64 and a beta of 1.56.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.11). The firm had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.50 billion. Select Medical had a net margin of 3.23% and a return on equity of 14.04%. Analysts anticipate that Select Medical Holdings Co. will post 1.17 earnings per share for the current fiscal year.

Select Medical Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 13th. Investors of record on Monday, March 3rd were paid a $0.0625 dividend. This represents a $0.25 annualized dividend and a dividend yield of 1.49%. The ex-dividend date was Monday, March 3rd. Select Medical’s payout ratio is presently 15.15%.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. Benchmark upgraded Select Medical from a “hold” rating to a “buy” rating and set a $23.00 target price for the company in a report on Monday, February 24th. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, February 21st. Royal Bank of Canada lowered their target price on Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a research note on Monday, February 24th. Finally, UBS Group reduced their price target on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, Select Medical currently has an average rating of “Moderate Buy” and an average price target of $27.25.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.